Additionally, our data also revealed that UroA repressed the expression of fibrotic markers (TGF-β and α-SMA), demonstrating that UroA could be beneficial for improving renal fibrosis (Supplementary Figure S4) in CKD progression. This evidence concerns the gene TGFB1 and chronic kidney disease.